Curist 5% Lidocaine Spray
NDC Package 72559-034-57

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Curist 5% Lidocaine (lidocaine 5%) sprays is usestemporarily shrinks hemorrhoidal tissue ■ temporarily reduces the swelling associated with irritation in hemorrhoids and other anorectal disorders ■ for the temporary relief of pain ■ for the temporary relief of local itching and discomfort in the perianal area. This formulation utilizes a spray delivery system. Marketed by Little Pharma, Inc., this product is identified by NDC 72559-034 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
72559-034-57
Package Description
177 mL in 1 CAN
Product Code
72559-034
11-Digit Billing Format
72559003457
RxNorm Crosswalk
  • RxCUI: 2168528 - lidocaine HCl 5 % / phenylephrine HCl 0.25 % Topical Spray
  • RxCUI: 2168528 - lidocaine hydrochloride 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Topical Spray
  • RxCUI: 2168528 - lidocaine hydrochloride 5 % / phenylephrine hydrochloride 0.25 % Topical Spray

Clinical Specifications

Proprietary Name
Curist 5% Lidocaine
Non-Proprietary Name
Lidocaine 5%
Substance Name
Lidocaine Hydrochloride; Phenylephrine Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Usestemporarily shrinks hemorrhoidal tissue ■ temporarily reduces the swelling associated with irritation in hemorrhoids and other anorectal disorders ■ for the temporary relief of pain ■ for the temporary relief of local itching and discomfort in the perianal area

Regulatory & Marketing

Labeler Name
Little Pharma, Inc.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-27-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72559-034-57 identifies a specific commercial package of 177 ml in 1 can of Curist 5% Lidocaine, a human over the counter drug labeled by Little Pharma, Inc.. This spray is formulated for topical use and contains lidocaine hydrochloride; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Little Pharma, Inc. on December 27, 2023. The current certification is valid through December 31, 2026.

How is this Little Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72559003457. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72559-034-57
11-Digit CMS (5-4-2)
72559-0034-57

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.